Related Experiment Video
Updated: Mar 22, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Elevation of troponin I in acute ischemic stroke
Yu-Chin Su1, Kuo-Feng Huang2, Fu-Yi Yang1
1Stroke Center and Department of Neurology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation , New Taipei City , Taiwan.
Insights
Elevated cardiac troponin I (TnI) in acute ischemic stroke patients independently predicts poor outcomes and in-hospital mortality. Early TnI assessment can improve stroke outcome prediction and guide cardiac investigations.
Area of Science:
- Cardiology
- Neurology
- Clinical Biomarkers
Background:
- Cardiac morbidities are a leading cause of death post-stroke.
- Elevated cardiac troponin I (TnI) is a known prognostic marker in acute stroke.
- This study investigates TnI's predictive value for outcomes in ischemic stroke.
Purpose of the Study:
- To evaluate the association between elevated TnI levels and clinical outcomes in patients with acute ischemic stroke.
- To determine if TnI improves the prediction of poor outcomes and in-hospital mortality.
Main Methods:
- Retrospective analysis of 871 acute ischemic stroke patients.
- Data collection included demographics, vital signs, lab parameters, and stroke severity scores (NIHSS, Barthel, mRS).
- Multivariate analysis and C-statistics were used to assess TnI's predictive power.
Main Results:
- 16.8% of patients had elevated TnI (> 0.01 µg/L).
- Elevated TnI was associated with older age, higher NIHSS scores, and poorer functional outcomes (higher mRS, lower Barthel index).
- Elevated TnI independently predicted poor outcome (OR 1.98) and in-hospital mortality (OR 5.59), significantly improving predictive models.
Conclusions:
- Elevated TnI is a strong independent predictor of poor outcomes and in-hospital mortality in acute ischemic stroke.
- TnI measurement enhances the predictive accuracy for adverse events.
- Patients with elevated TnI require thorough cardiac evaluation to identify potential co-existing cardiac conditions.
Abstract:
Background. Cardiac morbidities account for 20% of deaths after ischemic stroke and is the second commonest cause of death in acute stroke population. Elevation of cardiac troponin has been regarded as a prognostic biomarker of poor outcome in patients with acute stroke. Methods. This retrospective study enrolled 871 patients with acute ischemic stroke from August 2010 to March 2015. Data included vital signs, laboratory parameters collected in the emergency department, and clinical features during hospitalization. National Institutes of Health Stroke Scale (NIHSS), Barthel index, and modified Rankin Scale (mRS) were used to assess stroke severity and outcome. Results. Elevated troponin I (TnI) > 0.01 µg/L was observed in 146 (16.8%) patients. Comparing to patients with normal TnI, patients with elevated TnI were older (median age 77.6 years vs. 73.8 years), had higher median heart rates (80 bpm vs. 78 bpm), higher median white blood cells (8.40 vs. 7.50 1,000/m(3)) and creatinine levels (1.40 mg/dL vs. 1.10 mg/dL), lower median hemoglobin (13.0 g/dL vs. 13.7 g/dL) and hematocrit (39% vs. 40%) levels, higher median NIHSS scores on admission (11 vs. 4) and at discharge (8 vs. 3), higher median mRS scores (4 vs3) but lower Barthel index scores (20 vs. 75) at discharge (p < 0.001). Multivariate analysis revealed that age ≥ 76 years (OR 2.25, CI [1.59-3.18]), heart rate ≥ 82 bpm (OR 1.47, CI [1.05-2.05]), evidence of clinical deterioration (OR 9.45, CI [4.27-20.94]), NIHSS score ≥ 12 on admission (OR 19.52, CI [9.59-39.73]), and abnormal TnI (OR 1.98, CI [1.18-3.33]) were associated with poor outcome. Significant factors for in-hospital mortality included male gender (OR 3.69, CI [1.45-9.44]), evidence of clinical deterioration (OR 10.78, CI [4.59-25.33]), NIHSS score ≥ 12 on admission (OR 8.08, CI [3.04-21.48]), and elevated TnI level (OR 5.59, CI [2.36-13.27]). C-statistics revealed that abnormal TnI improved the predictive power of both poor outcome and in-hospital mortality. Addition of TnI > 0.01 ug/L or TnI > 0.1 ug/L to the model-fitting significantly improved c-statistics for in-hospital mortality from 0.887 to 0.926 (p = 0.019) and 0.927 (p = 0.028), respectively. Discussion. Elevation of TnI during acute stroke is a strong independent predictor for both poor outcome and in-hospital mortality. Careful investigation of possible concomitant cardiac disorders is warranted for patients with abnormal troponin levels.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management

